News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lanthio Pharma Receives Dutch Government Loan Of Up To €3.6 Million To Develop Novel Therapy For Lung Fibrosis


5/21/2014 9:03:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GRONINGEN, The Netherlands--(BUSINESS WIRE)--Lanthio Pharma B.V., the biopharmaceutical company focused on discovering and developing lanthipeptides, announced today that it has been awarded an Innovation Credit loan of up to €3.6 million by Dutch Government agency RVO. The Innovation Credit loan will support the development of LP2, an innovative lanthipeptide for treatment of Idiopathic Pulmonary Fibrosis.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES